WebWe apply our expertise to trials at all stages—from early development through approval—with embedded experience in oncology and rare disease. With over 2000 … WebMay 28, 2024 · Breethe, a company built on technology licensed out of the University of Maryland, Baltimore (UMB), was acquired by Abiomed, a publicly-traded medical device company located in Massachusetts, in late April 2024.
Our Work - Burdette, Koehler, Murphy & Associates
WebApr 29, 2024 · Breethe’s product is a first-of-its kind, easy-to-use compact ECMO system with an integrated oxygen concentrator that eliminates the need for bulky oxygen tanks to promote easier patient ambulation. WebRecognizing a substantial patient need and compelling commercial potential, Breethe was established as a company and sought seed capital to grow. In 2015 and 2016, Abell … cristian bravo alcalde
Breethe, Inc. Company Profile Halethorpe, MD Competitors ...
WebA University of Maryland, Baltimore-born medical device startup that has been developing a kind of artificial lung was acquired by publicly traded health technology firm Abiomed. Abiomed (NASDAQ: ABMD) announced Thursday its acquisition of Breethe Inc., a Maryland company based around technology that was spun out of UMB in 2014. WebBreethe's founder, Dr. Bartley Griffith, formed a unique team of world renowned experts in cardiothoracic surgery, researchers in fluid mechanics and product development engineers whose aim is to address a clinical need in treatment of chronic and acute lung disease. View Top Employees from Breethe, Inc. WebUtilization of the Abiomed Breethe OXY-1 System requires clinical judgment for patient risks vs benefits in all circumstances and requires specialized training in the use of cardiopulmonary bypass systems for safe operation … cristian calignano